Medical - - Jul 25,2017
As per statistics, the clinical laboratory services market in the UAE is expected to expand at a CAGR 5.4% between 2017 and 2025.
Clinical laboratory services include test types and service providers which are used to offer a high quality, clinical expertise and cost-effective service to the hospitals, and other healthcare units. The market for these services in the UAE are advancing as a result of rising incidence of infectious diseases, rising occurrence of chronic diseases, expanding geriatric population and the developing awareness of early detection and prevention.
As per a recent report published by Market Research Reports Search Engine (MRRSE), the UAE clinical laboratory services market is expected to exhibit a CAGR 5.4% between 2017 and 2025. If this pace is maintained, the valuation might reach a mark of US$2.6 bn by the end of the above stated period.
Further, considering the swelling incidence of chronic ailments such as HIV, Hepatitis C and other in the UAE, the requirement for effective clinical laboratory services is anticipated to surge in the coming years. It has been noticed that the government authorities in UAE, such as the Dubai Health Authority (DHA), the Ministry of Health (MoH) and Health Authority of Abu Dhabi (HAAD) are actively engaging in the development of healthcare infrastructure in the nation.
Also, it the next couple of years, the demand for medical hematology and microbiology is expected to rise at a higher pace. Besides this, the rising incidence of chronic ailments will fuel the demand for toxicology tests all across the UAE. Presently, the efficient players acting in this sector include Abbott, MIRACA HOLDINGS, Inc., Freiburg Medical Laboratories Middle East, Scientific Clinical Laboratories, National Reference Laboratories, Bio-reference Laboratories, Anglo Arabian Healthcare and Charles River Laboratories.
For more information on this report visit- http://www.mrrse.com/uae-clinical-laboratory-services-market